Disposition of 87500 shares by James Cunniff of Electromed subject to Rule 16b-3
ELMD Stock | USD 30.26 0.47 1.58% |
About 56% of all Electromed's shareholders are looking to take a long position. The analysis of overall sentiment of trading Electromed stock suggests that some investors are interested at this time. The current market sentiment, together with Electromed's historical and current headlines, can help investors time the market. In addition, many technical investors use Electromed stock news signals to limit their universe of possible portfolio assets.
Electromed |
Filed transaction by Electromed Director, Officer: Ceo And President. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at gurufocus.com
Electromed Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Electromed can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Electromed Fundamental Analysis
We analyze Electromed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Electromed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Electromed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Electromed is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Electromed Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Electromed stock to make a market-neutral strategy. Peer analysis of Electromed could also be used in its relative valuation, which is a method of valuing Electromed by comparing valuation metrics with similar companies.
Peers
Electromed Related Equities
NPCE | Neuropace | 9.90 | ||||
CNMD | CONMED | 3.51 | ||||
ITGR | Integer Holdings | 1.57 | ||||
KIDS | Orthopediatrics Corp | 1.03 | ||||
AXGN | Axogen | 0.97 | ||||
LIVN | LivaNova PLC | 0.84 | ||||
OFIX | Orthofix Medical | 0.69 | ||||
SRDX | SurModics | 0.58 | ||||
AORT | Artivion | 0.50 | ||||
IRMD | Iradimed | 0.30 | ||||
SGHT | Sight Sciences | 0.75 | ||||
FNA | Paragon 28 | 1.79 | ||||
LUNG | Pulmonx Corp | 2.65 |
Complementary Tools for Electromed Stock analysis
When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |